podophyllotoxin has been researched along with Leukemia, Myeloid, Acute, M4 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanada, S; Otsuka, M; Owatari, S; Takeshita, T; Uozumi, K | 1 |
| Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W | 1 |
| Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
1 review(s) available for podophyllotoxin and Leukemia, Myeloid, Acute, M4
| Article | Year |
|---|---|
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Topics: Alkylating Agents; Cell Cycle; Child; Chromosomes, Human, Pair 11; Clinical Trials as Topic; Drug Administration Schedule; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Topoisomerase II Inhibitors; Translocation, Genetic | 1994 |
2 other study(ies) available for podophyllotoxin and Leukemia, Myeloid, Acute, M4
| Article | Year |
|---|---|
Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
Topics: Acute Disease; Alkylating Agents; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin | 2007 |
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Leukemia, Myelomonocytic, Acute; Luteinizing Hormone; Melphalan; Menotropins; Ovulation Induction; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy, Multiple; Primary Ovarian Insufficiency; Remission Induction; Teniposide; Thioguanine; Vincristine | 1993 |